A open label, randomized, controled trial to assess the utility of Pitavastatin for patients with type2 diabetes and obesity in Matsuyama Shimin Hospital.

Trial Profile

A open label, randomized, controled trial to assess the utility of Pitavastatin for patients with type2 diabetes and obesity in Matsuyama Shimin Hospital.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Pitavastatin (Primary) ; Atorvastatin
  • Indications Hyperlipidaemia; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms POM
  • Most Recent Events

    • 14 Jan 2014 Planned End Date changed from 30 Jun 2014 to 31 Dec 2014, according to University Hospital Medical Information Network - Japan record.
    • 31 May 2013 Planned end date changed from 1 Jun 2013 to 30 Jun 2014 as reported by University Hospital Medical Information Network - Japan.
    • 30 Jun 2012 Planned end date (Jun 2013) added as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top